Carboplatin, Ixabepilone, and Cetuximab in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Untreated With Chemotherapy

NCT00998101 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study was withdrawn due issuses related to the science

Conditions

Lung Cancer

Interventions

DRUG: cetuximab
DRUG: carboplatin
DRUG: ixabepilone

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]